Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04725422 · ClinicalTrials.gov registry record

CHronic Nonbacterial Osteomyelitis International Registry

A clinical trial of Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis, sponsored by Seattle Children's Hospital.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT04725422 is a study of Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04725422, a study of Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis, is actively recruiting participants, sponsored by Seattle Children's Hospital.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

The objective of the study is to establish a prospective disease registry for chronic recurrent multifocal osteomyelitis (CRMO)/chronic nonbacterial osteomyelitis (CNO) in order to investigate the natural history of the disease and the responses of patients to different clinical managements over 10 years.

Interventions

  • DRUG Zoledronic acid
  • DRUG Methotrexate
  • DRUG Leflunomide
  • DRUG Sulfasalazine
  • DRUG Pamidronate

Study Locations (1)

Washington

  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2018-08-01
Est. Completion 2050-08

Sponsor

Seattle Children's Hospital

168 total trials

What the Registry Record Tells You About NCT04725422

The ClinicalTrials.gov registry entry for NCT04725422 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Nonbacterial Osteomyelitis appearing as the primary indexed condition, and to 5 interventions - of which Zoledronic acid is the first listed.

NCT04725422 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT04725422 about?

NCT04725422 is a clinical study titled "CHronic Nonbacterial Osteomyelitis International Registry". The objective of the study is to establish a prospective disease registry for chronic recurrent multifocal osteomyelitis (CRMO)/chronic nonbacterial osteomyelitis (CNO) in order to investigate the natural history of the disease and the responses of patients to different clinical managements over 10 ...

What is the current status of trial NCT04725422?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2018-08-01. Estimated completion is 2050-08.

What conditions does trial NCT04725422 study?

This clinical trial studies the following conditions: Chronic Nonbacterial Osteomyelitis, Chronic Recurrent Multifocal Osteomyelitis.

What interventions are being tested in trial NCT04725422?

The interventions under investigation include: Zoledronic acid (DRUG), Methotrexate (DRUG), Leflunomide (DRUG), Sulfasalazine (DRUG), Pamidronate (DRUG).

Who is sponsoring clinical trial NCT04725422?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04725422 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.